author-photo

Jane Hook

University College London

21

Papers

1555

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Quality of Life with weekly platinum-based chemotherapy in newly diagnosed Ovarian Cancer: the ICON8 phase III randomised controlled clinical trial

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (0)
805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
ICON8 Stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

2015 The Lancet
Show All
- Source
- Cite
- Save
Citations (666)
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (181)
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (237)
ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
When Should Surgery Be Performed for the First-Line Treatment of Advanced Ovarian Cancer?

2014
Show All
- Source
- Cite
- Save
Citations (0)
Maintenance therapy in ovarian cancer.

2014 Current Opinion in Oncology
Show All
- Source
- Cite
- Save
Citations (19)
MAPIE vs MAP as postoperative chemotherapy in patients with a poor response to preoperative chemotherapy for newly-diagnosed osteosarcoma: results from EURAMOS-1 (Paper 032)

2014
Show All
- Source
- Cite
- Save
Citations (15)